Annual accounts receivable:
$1.47M+$595.00K(+68.08%)Summary
- As of today (July 1, 2025), XENE annual accounts receivable is $1.47 million, with the most recent change of +$595.00 thousand (+68.08%) on December 31, 2024.
- During the last 3 years, XENE annual accounts receivable has fallen by -$1.30 million (-46.87%).
- XENE annual accounts receivable is now -46.87% below its all-time high of $2.77 million, reached on December 31, 2021.
Performance
XENE Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$8.65M+$7.18M(+488.77%)Summary
- As of today (July 1, 2025), XENE quarterly accounts receivable is $8.65 million, with the most recent change of +$7.18 million (+488.77%) on March 31, 2025.
- Over the past year, XENE quarterly accounts receivable has increased by +$7.82 million (+938.30%).
- XENE quarterly accounts receivable is now at all-time high.
Performance
XENE Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
XENE Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +68.1% | +938.3% |
| 3 y3 years | -46.9% | +195.9% |
| 5 y5 years | +80.7% | +434.9% |
XENE Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.9% | +68.1% | at high | +974.4% |
| 5 y | 5-year | -46.9% | +80.7% | at high | +974.4% |
| alltime | all time | -46.9% | +872.9% | at high | +6604.6% |
XENE Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $8.65M(+488.8%) |
| Dec 2024 | $1.47M(+68.1%) | $1.47M(+56.6%) |
| Sep 2024 | - | $938.00K(+10.0%) |
| Jun 2024 | - | $853.00K(+2.4%) |
| Mar 2024 | - | $833.00K(-4.7%) |
| Dec 2023 | $874.00K(-11.4%) | $874.00K(+8.6%) |
| Sep 2023 | - | $805.00K(-62.1%) |
| Jun 2023 | - | $2.12M(-4.5%) |
| Mar 2023 | - | $2.22M(+125.4%) |
| Dec 2022 | $986.00K(-64.3%) | $986.00K(-60.3%) |
| Sep 2022 | - | $2.48M(-1.7%) |
| Jun 2022 | - | $2.52M(-13.7%) |
| Mar 2022 | - | $2.92M(+5.7%) |
| Dec 2021 | $2.77M(+51.8%) | $2.77M(-14.5%) |
| Sep 2021 | - | $3.23M(+10.8%) |
| Jun 2021 | - | $2.92M(-42.3%) |
| Mar 2021 | - | $5.06M(+177.7%) |
| Dec 2020 | $1.82M(+124.1%) | $1.82M(+13.2%) |
| Sep 2020 | - | $1.61M(-9.9%) |
| Jun 2020 | - | $1.79M(+10.5%) |
| Mar 2020 | - | $1.62M(+98.9%) |
| Dec 2019 | $813.00K | $813.00K(+289.0%) |
| Sep 2019 | - | $209.00K(+22.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $171.00K(+29.5%) |
| Mar 2019 | - | $132.00K(-12.6%) |
| Dec 2018 | $151.00K(-65.5%) | $151.00K(-16.1%) |
| Sep 2018 | - | $180.00K(+5.3%) |
| Jun 2018 | - | $171.00K(-60.4%) |
| Mar 2018 | - | $432.00K(-1.4%) |
| Dec 2017 | $438.00K(+119.0%) | $438.00K(+239.5%) |
| Sep 2017 | - | $129.00K(-34.8%) |
| Jun 2017 | - | $198.00K(+4.8%) |
| Mar 2017 | - | $189.00K(-5.5%) |
| Dec 2016 | $200.00K(-36.5%) | $200.00K(-66.4%) |
| Sep 2016 | - | $595.00K(-9.6%) |
| Jun 2016 | - | $658.00K(+70.5%) |
| Mar 2016 | - | $386.00K(+22.5%) |
| Dec 2015 | $315.00K(+46.5%) | $315.00K(+15.0%) |
| Sep 2015 | - | $274.00K(+45.7%) |
| Jun 2015 | - | $188.00K(-84.4%) |
| Mar 2015 | - | $1.21M(+460.5%) |
| Dec 2014 | $215.00K(-51.1%) | $215.00K(+32.7%) |
| Sep 2014 | - | $162.00K(-55.5%) |
| Jun 2014 | - | $364.00K(-17.3%) |
| Dec 2013 | $440.00K(+12.2%) | $440.00K |
| Dec 2012 | $392.00K | - |
FAQ
- What is Xenon Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual accounts receivable year-on-year change?
- What is Xenon Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Xenon Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of XENE is $1.47M
What is the all time high annual accounts receivable for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual accounts receivable is $2.77M
What is Xenon Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, XENE annual accounts receivable has changed by +$595.00K (+68.08%)
What is Xenon Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of XENE is $8.65M
What is the all time high quarterly accounts receivable for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly accounts receivable is $8.65M
What is Xenon Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, XENE quarterly accounts receivable has changed by +$7.82M (+938.30%)